Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Robust DNA Damage Response and Elevated Reactive Oxygen Species in TINF2-Mutated Dyskeratosis Congenita Cells.

Pereboeva L, Hubbard M, Goldman FD, Westin ER.

PLoS One. 2016 Feb 9;11(2):e0148793. doi: 10.1371/journal.pone.0148793. eCollection 2016.

2.

A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation.

Nelson AS, Marsh RA, Myers KC, Davies SM, Jodele S, O'Brien TA, Mehta PA.

Biol Blood Marrow Transplant. 2016 May;22(5):884-8. doi: 10.1016/j.bbmt.2016.01.026. Epub 2016 Feb 1.

PMID:
26845033
3.

Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.

Babushok DV, Bessler M, Olson TS.

Leuk Lymphoma. 2016;57(3):520-36. doi: 10.3109/10428194.2015.1115041. Epub 2015 Dec 23.

PMID:
26693794
4.

Radiation Sensitivity and Radiation Necrosis in the Short Telomere Syndromes.

Stanley SE, Rao AD, Gable DL, McGrath-Morrow S, Armanios M.

Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):1115-7. doi: 10.1016/j.ijrobp.2015.08.048. Epub 2015 Sep 4. No abstract available. Erratum in: Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):423.

5.

The short and long telomere syndromes: paired paradigms for molecular medicine.

Stanley SE, Armanios M.

Curr Opin Genet Dev. 2015 Aug;33:1-9. doi: 10.1016/j.gde.2015.06.004. Epub 2015 Jul 29. Review.

PMID:
26232116
6.

Telomere dysfunction causes alveolar stem cell failure.

Alder JK, Barkauskas CE, Limjunyawong N, Stanley SE, Kembou F, Tuder RM, Hogan BL, Mitzner W, Armanios M.

Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):5099-104. doi: 10.1073/pnas.1504780112. Epub 2015 Apr 3.

7.

From marrow to matrix: novel gene and cell therapies for epidermolysis bullosa.

Webber BR, Tolar J.

Mol Ther. 2015 Jun;23(6):987-92. doi: 10.1038/mt.2015.47. Epub 2015 Mar 24. Review.

8.

Alternative donor transplant of benign primary hematologic disorders.

Tolar J, Sodani P, Symons H.

Bone Marrow Transplant. 2015 May;50(5):619-27. doi: 10.1038/bmt.2015.1. Epub 2015 Feb 9. Review.

9.

Advances in unrelated and alternative donor hematopoietic cell transplantation for nonmalignant disorders.

Shenoy S, Boelens JJ.

Curr Opin Pediatr. 2015 Feb;27(1):9-17. doi: 10.1097/MOP.0000000000000179. Review.

10.

Lung transplantation in telomerase mutation carriers with pulmonary fibrosis.

Silhan LL, Shah PD, Chambers DC, Snyder LD, Riise GC, Wagner CL, Hellström-Lindberg E, Orens JB, Mewton JF, Danoff SK, Arcasoy MO, Armanios M.

Eur Respir J. 2014 Jul;44(1):178-87. doi: 10.1183/09031936.00060014. Epub 2014 May 15.

11.

DNA damage responses and oxidative stress in dyskeratosis congenita.

Pereboeva L, Westin E, Patel T, Flaniken I, Lamb L, Klingelhutz A, Goldman F.

PLoS One. 2013 Oct 4;8(10):e76473. doi: 10.1371/journal.pone.0076473. eCollection 2013.

12.

Telomere biology and translational research.

Mason PJ, Perdigones N.

Transl Res. 2013 Dec;162(6):333-42. doi: 10.1016/j.trsl.2013.08.009. Epub 2013 Sep 23. Review. No abstract available.

13.

Bone marrow transplantation in Schimke immuno-osseous dysplasia.

Baradaran-Heravi A, Lange J, Asakura Y, Cochat P, Massella L, Boerkoel CF.

Am J Med Genet A. 2013 Oct;161A(10):2609-13. doi: 10.1002/ajmg.a.36111. Epub 2013 Aug 15. Review.

14.

Recognizing familial myeloid leukemia in adults.

Nickels EM, Soodalter J, Churpek JE, Godley LA.

Ther Adv Hematol. 2013 Aug;4(4):254-69. doi: 10.1177/2040620713487399.

15.

Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita.

Gadalla SM, Sales-Bonfim C, Carreras J, Alter BP, Antin JH, Ayas M, Bodhi P, Davis J, Davies SM, Deconinck E, Deeg HJ, Duerst RE, Fasth A, Ghavamzadeh A, Giri N, Goldman FD, Kolb EA, Krance R, Kurtzberg J, Leung WH, Srivastava A, Or R, Richman CM, Rosenberg PS, Toledo Codina JS, Shenoy S, Socié G, Tolar J, Williams KM, Eapen M, Savage SA.

Biol Blood Marrow Transplant. 2013 Aug;19(8):1238-43. doi: 10.1016/j.bbmt.2013.05.021. Epub 2013 Jun 8.

16.

Telomeres and age-related disease: how telomere biology informs clinical paradigms.

Armanios M.

J Clin Invest. 2013 Mar;123(3):996-1002. doi: 10.1172/JCI66370. Epub 2013 Mar 1. Review.

17.

Neuropsychiatric conditions among patients with dyskeratosis congenita: a link with telomere biology?

Rackley S, Pao M, Seratti GF, Giri N, Rasimas JJ, Alter BP, Savage SA.

Psychosomatics. 2012 May-Jun;53(3):230-5. doi: 10.1016/j.psym.2011.09.003. Epub 2012 Mar 27.

18.

Revertant somatic mosaicism by mitotic recombination in dyskeratosis congenita.

Jongmans MC, Verwiel ET, Heijdra Y, Vulliamy T, Kamping EJ, Hehir-Kwa JY, Bongers EM, Pfundt R, van Emst L, van Leeuwen FN, van Gassen KL, Geurts van Kessel A, Dokal I, Hoogerbrugge N, Ligtenberg MJ, Kuiper RP.

Am J Hum Genet. 2012 Mar 9;90(3):426-33. doi: 10.1016/j.ajhg.2012.01.004. Epub 2012 Feb 16.

19.

The genetics of dyskeratosis congenita.

Mason PJ, Bessler M.

Cancer Genet. 2011 Dec;204(12):635-45. doi: 10.1016/j.cancergen.2011.11.002. Review.

20.

Telomerase and idiopathic pulmonary fibrosis.

Armanios M.

Mutat Res. 2012 Feb 1;730(1-2):52-8. doi: 10.1016/j.mrfmmm.2011.10.013. Epub 2011 Nov 4. Review.

Items per page

Supplemental Content

Write to the Help Desk